[Trend of research and development of antihypertensive agents]

Nihon Rinsho. 2006 Jul:64 Suppl 5:583-7.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Amides
  • Angiotensin II Type 1 Receptor Blockers* / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Angiotensins / immunology
  • Antihypertensive Agents* / therapeutic use
  • Aspartic Acid Endopeptidases / antagonists & inhibitors
  • Benzimidazoles* / therapeutic use
  • Biphenyl Compounds
  • Drug Combinations
  • Drug Design
  • Endothelin Receptor Antagonists
  • Endothelin-Converting Enzymes
  • Fumarates / therapeutic use
  • Humans
  • Hypertension / therapy*
  • Immunotherapy, Active
  • Metalloendopeptidases / antagonists & inhibitors
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Phenylpropionates / therapeutic use
  • Pyrimidines / therapeutic use
  • Randomized Controlled Trials as Topic
  • Renin / antagonists & inhibitors
  • Tetrazoles* / therapeutic use

Substances

  • Amides
  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensins
  • Antihypertensive Agents
  • Benzimidazoles
  • Biphenyl Compounds
  • Drug Combinations
  • Endothelin Receptor Antagonists
  • Fumarates
  • Mineralocorticoid Receptor Antagonists
  • Phenylpropionates
  • Pyrimidines
  • Tetrazoles
  • darusentan
  • aliskiren
  • Aspartic Acid Endopeptidases
  • Renin
  • Metalloendopeptidases
  • Endothelin-Converting Enzymes
  • candesartan